Flupirtine and retigabine as templates for ligand-based drug design of KV7.2/3 activators.

MLA

Surur, Abdrrahman S., et al. “Flupirtine and Retigabine as Templates for Ligand-Based Drug Design of KV7.2/3 Activators.” Organic & Biomolecular Chemistry, vol. 17, no. 18, May 2019, pp. 4512–22. EBSCOhost, https://doi.org/10.1039/c9ob00511k.

APA

Surur, A. S., Bock, C., Beirow, K., Wurm, K., Schulig, L., Kindermann, M. K., Siegmund, W., Bednarski, P. J., & Link, A. (2019). Flupirtine and retigabine as templates for ligand-based drug design of KV7.2/3 activators. Organic & Biomolecular Chemistry, 17(18), 4512–4522. https://doi.org/10.1039/c9ob00511k

Chicago

Surur, Abdrrahman S., Christian Bock, Kristin Beirow, Konrad Wurm, Lukas Schulig, Markus K. Kindermann, Werner Siegmund, Patrick J. Bednarski, and Andreas Link. 2019. “Flupirtine and Retigabine as Templates for Ligand-Based Drug Design of KV7.2/3 Activators.” Organic & Biomolecular Chemistry 17 (18): 4512–22. doi:10.1039/c9ob00511k.